All Stories

  1. Apigenin Induces Autophagy and Apoptosis in Chemoresistant Glioblastoma Cells and Inhibits Tumorigenicity Associated with Regulation of Immunomodulatory Proteins and Glial Cells Response

    Article • Cells, October 2025, MDPI AG

    Dr Herve Chneiweiss

  2. The value of large-scale programmes in human genomics

    Article • European Journal of Human Genetics, April 2025, Springer Science + Business Media

    Dr Herve Chneiweiss

  3. Ethical and social implications of public–private partnerships in the context of genomic/big health data collection

    Article • European Journal of Human Genetics, April 2024, Springer Science + Business Media

    Dr Herve Chneiweiss

  4. Pour une bonne compréhension et un bon usage du terme « organoïdes »

    Article • médecine/sciences, November 2023, EDP Sciences

    Dr Herve Chneiweiss

  5. CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3

    Article • Cancers, October 2023, MDPI AG

    Dr Herve Chneiweiss

  6. Challenges in glioblastoma research: focus on the tumor microenvironment

    Article • Trends in Cancer, August 2023, Elsevier

    Professor Isabelle Fournier, Dr Herve Chneiweiss

  7. 2023 : premiers succès et nouveaux enjeux de l’édition du génome en thérapeutique humaine

    Article • médecine/sciences, August 2023, EDP Sciences

    Dr Herve Chneiweiss

  8. Challenges in glioblastoma research: focus on the tumor microenvironment

    Article • Trends in Cancer, January 2023, Elsevier

    Professor Isabelle Fournier, Dr Herve Chneiweiss

  9. Managing expectations, rights, and duties in large-scale genomics initiatives: a European comparison

    Article • European Journal of Human Genetics, December 2022, Springer Science + Business Media

    Dr Herve Chneiweiss

  10. Glioblastoma cell motility depends on enhanced oxidative stress coupled with mobilization of a sulfurtransferase

    Article • Cell Death and Disease, October 2022, Springer Science + Business Media

    Dr Herve Chneiweiss

  11. Axel Kahn : l’exigence comme nécessité d’une pensée juste

    Article • médecine/sciences, December 2021, EDP Sciences

    Dr Herve Chneiweiss

  12. Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine

    Article • Nature, March 2021, Springer Science + Business Media

    Dr Herve Chneiweiss, Dr Giacomo Cavalli, Catherine Brooksbank

  13. Sur les épaules des géants qui nous ont précédés

    Article • médecine/sciences, February 2021, EDP Sciences

    Dr Herve Chneiweiss

  14. The ethics of genomic medicine: redefining values and norms in the UK and France

    Article • European Journal of Human Genetics, January 2021, Springer Science + Business Media

    Dr Herve Chneiweiss

  15. The HIF1α/JMY pathway promotes glioblastoma stem-like cell invasiveness after irradiation

    Article • Scientific Reports, October 2020, Springer Science + Business Media

    Dr Herve Chneiweiss

  16. Global citizen deliberation on genome editing

    Article • Science, September 2020, American Association for the Advancement of Science

    Dr Herve Chneiweiss

  17. LifeTime and improving European healthcare through cell-based interceptive medicine

    Article • Nature, September 2020, Springer Science + Business Media

    Dr Christoph Bock, Dr Herve Chneiweiss, Dr Giacomo Cavalli, Catherine Brooksbank

  18. ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells

    Article • Cancer Research, May 2020, American Association for Cancer Research (AACR)

    Dr Herve Chneiweiss

  19. Covid-19 : protocoles de soins ou protocoles de recherche ?

    Article • médecine/sciences, May 2020, EDP Sciences

    Dr Herve Chneiweiss

  20. Organoïdes : nouvelles perspectives et nouvelles questions éthiques

    Article • médecine/sciences, February 2020, EDP Sciences

    Dr Herve Chneiweiss

  21. Capture at the single cell level of metabolic modules distinguishing aggressive and indolent glioblastoma cells

    Article • Acta Neuropathologica Communications, October 2019, Springer Science + Business Media

    Dr Herve Chneiweiss

  22. Capture at the single cell level of metabolic modules distinguishing aggressive and indolent glioblastoma cells

    Article • September 2019, Cold Spring Harbor Laboratory Press

    Dr Herve Chneiweiss

  23. The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models

    Article • Nature Communications, May 2019, Springer Science + Business Media

    Dr Herve Chneiweiss

  24. The flavonoid rutin and its aglycone quercetin modulate the microglia inflammatory profile improving antiglioma activity

    Article • Brain Behavior and Immunity, May 2019, Elsevier

    Dr Herve Chneiweiss

  25. Genome Editing: Promoting Responsible Research

    Article • Pharmaceutical Medicine, April 2019, Springer Science + Business Media

    Dr Herve Chneiweiss

  26. De retour de Hong Kong ou l’éthique à l’heure d’une génétique d’« augmentation » de la personne humaine

    Article • médecine/sciences, March 2019, EDP Sciences

    Dr Herve Chneiweiss

  27. Éléments pour une éthique de la communication des faits scientifiques

    Article • médecine/sciences, February 2019, EDP Sciences

    Dr Herve Chneiweiss

  28. ALT cancer cells are specifically sensitive to lysine acetyl transferase inhibition

    Article • Oncotarget, January 2019, Impact Journals, LLC

    Dr Herve Chneiweiss

  29. WNK1 kinase and its partners Akt, SGK1 and NBC-family Na+/HCO3– cotransporters are potential therapeutic targets for glioblastoma stem-like cells linked to Bisacodyl signaling

    Article • Oncotarget, May 2018, Impact Journals, LLC

    Dr Herve Chneiweiss

  30. The tsunami named CRISPR/Cas9

    Article • Revue Neurologique, May 2018, Elsevier

    Dr Herve Chneiweiss

  31. Could Failure in Preimplantation Genetic Diagnosis Justify Editing the Human Embryo Genome?

    Article • Cell Stem Cell, April 2018, Elsevier

    Dr Herve Chneiweiss

  32. ARRIGE Arrives: Toward the Responsible Use of Genome Editing

    Article • The CRISPR Journal, April 2018, Mary Ann Liebert Inc

    Dr Herve Chneiweiss

  33. Radiosensitization Effect of Talazoparib, a Parp Inhibitor, on Glioblastoma Stem Cells Exposed to Low and High Linear Energy Transfer Radiation

    Article • Scientific Reports, February 2018, Springer Science + Business Media

    Dr Herve Chneiweiss

  34. Les états généraux de la bioéthique de 2018

    Article • médecine/sciences, February 2018, EDP Sciences

    Dr Herve Chneiweiss

  35. Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma

    Article • Cancer Cell, December 2017, Elsevier

    Dr Herve Chneiweiss

  36. Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness

    Article • Acta Neuropathologica, November 2017, Springer Science + Business Media

    Dr Herve Chneiweiss

  37. Glut3 addiction is a druggable vulnerability for a molecularly defined subpopulation of glioblastoma

    Article • Annals of Oncology, October 2017, Elsevier

    Dr Herve Chneiweiss

  38. Commentary: Just Say “No”

    Article • Cambridge Quarterly of Healthcare Ethics, September 2017, Cambridge University Press

    Dr Herve Chneiweiss

  39. DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression

    Article • Oncogene, September 2017, Springer Science + Business Media

    Dr Herve Chneiweiss

  40. Fostering responsible research with genome editing technologies: a European perspective

    Article • Transgenic Research, July 2017, Springer Science + Business Media

    Dr Herve Chneiweiss

  41. Bisacodyl and its cytotoxic activity on human glioblastoma stem-like cells. Implication of inositol 1,4,5-triphosphate receptor dependent calcium signaling

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, June 2017, Elsevier

    Dr Herve Chneiweiss

  42. Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth

    Article • Cell Death and Disease, March 2017, Nature

    Dr Herve Chneiweiss

  43. Opposite effects of GCN5 and PCAF knockdowns on the alternative mechanism of telomere maintenance

    Article • Oncotarget, February 2017, Impact Journals, LLC

    Dr Herve Chneiweiss

  44. Development of a DIPG Orthotopic Model in Mice Using an Implantable Guide-Screw System

    Article • PLOS One, January 2017, PLOS

    Dr Herve Chneiweiss

  45. A European position on genome editing

    Article • Nature, January 2017, Springer Science + Business Media

    Dr Herve Chneiweiss

  46. A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma

    Article • Acta Neuropathologica, December 2016, Springer Science + Business Media

    Dr Herve Chneiweiss

  47. CHD7 promotes proliferation of neural stem cells mediated by MIF

    Article • Molecular Brain, December 2016, Springer Science + Business Media

    Dr Herve Chneiweiss

  48. EXTH-09. LOOKING FOR A CURE: DELTA-24-RDG AND RADIOTHERAPY FOR DIPG TREATMENT

    Article • Neuro-Oncology, November 2016, Oxford University Press (OUP)

    Dr Herve Chneiweiss

  49. Nos jeunes pousses ont du talent !

    Article • médecine/sciences, June 2016, EDP Sciences

    Dr Herve Chneiweiss

  50. HG-51DELTA-24-RDG IN COMBINATION WITH RADIOTHERAPY FOR DIPG: OPENING NEW THERAPEUTIC AVENUES

    Article • Neuro-Oncology, June 2016, Oxford University Press (OUP)

    Dr Herve Chneiweiss

  51. Calcium signaling orchestrates glioblastoma development: Facts and conjunctures

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, June 2016, Elsevier

    Dr Herve Chneiweiss

  52. The anti‐hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ‐dependent inhibition of the AKT pathway

    Article • EMBO Molecular Medicine, April 2016, EMBO

    Dr Herve Chneiweiss

  53. A Positive Feed-forward Loop Associating EGR1 and PDGFA Promotes Proliferation and Self-renewal in Glioblastoma Stem Cells

    Article • Journal of Biological Chemistry, March 2016, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Herve Chneiweiss

  54. La recherche biomédicale pensée en français : Nouvelle année, nouveaux concepts

    Article • médecine/sciences, January 2016, EDP Sciences

    Dr Herve Chneiweiss

  55. Flavonoids suppress human glioblastoma cell growth by inhibiting cell metabolism, migration, and by regulating extracellular matrix proteins and metalloproteinases expression

    Article • Chemico-Biological Interactions, December 2015, Elsevier

    Dr Herve Chneiweiss

  56. Absence of the Adaptor Protein PEA-15 Is Associated with Altered Pattern of Th Cytokines Production by Activated CD4+ T Lymphocytes In Vitro, and Defective Red Blood Cell Alloimmune Response In Vivo

    Article • PLOS One, August 2015, PLOS

    Dr Herve Chneiweiss

  57. Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells

    Article • PLOS One, August 2015, PLOS

    Dr Herve Chneiweiss

  58. Connective-Tissue Growth Factor (CTGF/CCN2) Induces Astrogenesis and Fibronectin Expression of Embryonic Neural Cells In Vitro

    Article • PLOS One, August 2015, PLOS

    Dr Herve Chneiweiss

  59. Une éthique de dialogue science-société

    Article • médecine/sciences, June 2015, EDP Sciences

    Dr Herve Chneiweiss

  60. Les années 2010

    Article • médecine/sciences, March 2015, EDP Sciences

    Dr Jean-Luc Teillaud, Dr Herve Chneiweiss

  61. Les années 2000

    Article • médecine/sciences, March 2015, EDP Sciences

    M.D. DANIEL G BICHET, Dr Herve Chneiweiss

  62. Data in support of metabolic reprogramming in transformed mouse cortical astrocytes: A proteomic study

    Article • Data in Brief, March 2015, Elsevier

    Dr Herve Chneiweiss

  63. 30 ans déjà, et demain ?

    Article • médecine/sciences, March 2015, EDP Sciences

    Dr Herve Chneiweiss

  64. Depuis 30 ans, aujourd’hui et demain : transmettre la science biomédicale en langue française

    Article • médecine/sciences, February 2015, EDP Sciences

    Dr Herve Chneiweiss

  65. Metabolic reprogramming in transformed mouse cortical astrocytes: A proteomic study

    Article • Journal of Proteomics, January 2015, Elsevier

    Dr Herve Chneiweiss

  66. A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT)

    Article • International Journal of Cancer, September 2014, Wiley

    Dr Herve Chneiweiss

  67. Lamarck en invité spécial du 30eanniversaire dem/s

    Article • médecine/sciences, August 2014, EDP Sciences

    Dr Herve Chneiweiss

  68. SIRT2, une déacétylase aux multiples talents

    Article • médecine/sciences, May 2014, EDP Sciences

    Dr Herve Chneiweiss

  69. Endothelial Secreted Factors Suppress Mitogen Deprivation-Induced Autophagy and Apoptosis in Glioblastoma Stem-Like Cells

    Article • PLOS One, March 2014, PLOS

    Dr Herve Chneiweiss

  70. Comparative Expression Study of the Endo–G Protein Coupled Receptor (GPCR) Repertoire in Human Glioblastoma Cancer Stem-like Cells, U87-MG Cells and Non Malignant Cells of Neural Origin Unveils New Potential Therapeutic Targets

    Article • PLOS One, March 2014, PLOS

    Dr Herve Chneiweiss

  71. À quoi sert donc une revue scientifique en langue française ?

    Article • médecine/sciences, January 2014, EDP Sciences

    Dr Herve Chneiweiss

  72. A cell-penetrating peptide based on the interaction between c-Src and connexin43 reverses glioma stem cell phenotype

    Article • Cell Death and Disease, January 2014, Springer Science + Business Media

    Dr Herve Chneiweiss

  73. The relationship between brain tumor cell invasion of engineered neural tissues and in vivo features of glioblastoma

    Article • Biomaterials, November 2013, Elsevier

    Dr Herve Chneiweiss

  74. Sirtuin-2 Activity is Required for Glioma Stem Cell Proliferation Arrest but not Necrosis Induced by Resveratrol

    Article • Stem Cell Reviews and Reports, August 2013, Springer Science + Business Media

    Dr Herve Chneiweiss

  75. Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis and favors glioblastoma resistance to etoposide

    Article • Cell Death and Disease, August 2013, Springer Science + Business Media

    Dr Herve Chneiweiss

  76. Tumorigenic Potential of miR-18A* in Glioma Initiating Cells Requires NOTCH-1 Signaling

    Article • Stem Cells, July 2013, Wiley

    Dr Herve Chneiweiss

  77. Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies

    Article • PROTEOMICS - CLINICAL APPLICATIONS, January 2013, Wiley

    Dr Herve Chneiweiss

  78. médecine/sciences2013

    Article • médecine/sciences, January 2013, EDP Sciences

    Dr Herve Chneiweiss

  79. Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation

    Article • Journal of Cell Science, June 2012, The Company of Biologists

    Dr Herve Chneiweiss

  80. Differential Proteomic Analysis of Human Glioblastoma and Neural Stem Cells Reveals HDGF as a Novel Angiogenic Secreted Factor

    Article • Stem Cells, April 2012, Wiley

    Dr Herve Chneiweiss

  81. Antiproliferative Activity of trans- Avicennol from Zanthoxylum chiloperone var. angustifolium against Human Cancer Stem Cells

    Article • Journal of Natural Products, February 2012, American Chemical Society (ACS)

    Dr Herve Chneiweiss

  82. Alkaloids from Rutaceae: activities of canthin-6-one alkaloids and synthetic analogues on glioblastoma stems cells

    Article • MedChemComm, January 2012, Royal Society of Chemistry

    Dr Herve Chneiweiss

  83. médecine/sciencesacteur de la bioéconomie responsable

    Article • médecine/sciences, January 2012, EDP Sciences

    Dr Herve Chneiweiss

  84. Proteomic analysis of oligodendrogliomas expressing a mutant isocitrate dehydrogenase-1

    Article • PROTEOMICS, September 2011, Wiley

    Dr LUC CAMOIN, Dr Herve Chneiweiss

  85. The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network

    Article • Cell Death and Differentiation, July 2011, Springer Science + Business Media

    Dr Herve Chneiweiss

  86. Does Cognitive Enhancement Fit with the Physiology of Our Cognition?

    Article • April 2011, Oxford University Press (OUP)

    Dr Herve Chneiweiss

  87. Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway

    Article • EMBO Reports, April 2011, Wiley

    Dr Herve Chneiweiss

  88. Alternative Lengthening of Telomeres in Human Glioma Stem Cells

    Article • Stem Cells, March 2011, Wiley

    Dr Herve Chneiweiss

  89. Clinical Relevance of Tumor Cells with Stem-Like Properties in Pediatric Brain Tumors

    Article • PLOS One, January 2011, PLOS

    Dr Herve Chneiweiss

  90. Cerveau préservé, réparé, amélioré

    Article • Médecine & Droit, January 2011, Elsevier

    Dr Herve Chneiweiss

  91. Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells

    Article • Molecular Cancer, January 2011, Springer Science + Business Media

    Dr Herve Chneiweiss

  92. médecine/sciences2011

    Article • médecine/sciences, January 2011, EDP Sciences

    Dr Herve Chneiweiss

  93. Plasticité du phénotype cellulaire ou une certaine fin de l’insouciance du déterminisme

    Article • Biologie Aujourd hui, January 2011, EDP Sciences

    Dr Herve Chneiweiss

  94. NG2+/Olig2+Cells are the Major Cycle-Related Cell Population of the Adult Human Normal Brain

    Article • Brain Pathology, March 2010, Wiley

    Dr Herve Chneiweiss

  95. CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors

    Article • BMC Cancer, February 2010, Springer Science + Business Media

    Dr Herve Chneiweiss

  96. An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients

    Article • Molecular Cancer, January 2010, Springer Science + Business Media

    Dr Herve Chneiweiss

  97. Neurosciences et neuroéthique

    Article • January 2010, CAIRN

    Dr Herve Chneiweiss

  98. Astrocytes Reverted to a Neural Progenitor-like State with Transforming Growth Factor Alpha Are Sensitized to Cancerous Transformation

    Article • Stem Cells, October 2009, Wiley

    Dr Herve Chneiweiss

  99. Calcium fingerprints induced by Calmodulin interactors in eukaryotic cells

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, June 2009, Elsevier

    Dr Herve Chneiweiss

  100. Development of Human Nervous Tissue upon Differentiation of Embryonic Stem Cells in Three-Dimensional Culture

    Article • Stem Cells, March 2009, Wiley

    Dr Herve Chneiweiss

  101. DLG1/SAP97 modulates transforming growth factor α bioavailability

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, February 2009, Elsevier

    Dr Herve Chneiweiss

  102. GFAPδ immunostaining improves visualization of normal and pathologic astrocytic heterogeneity

    Article • Neuropathology, February 2009, Wiley

    Dr Herve Chneiweiss

  103. Médecine/Scienceset les passerelles du temps

    Article • médecine/sciences, January 2009, EDP Sciences

    Dr Herve Chneiweiss

  104. Dans la lumière et les ombres

    Article • médecine/sciences, December 2008, EDP Sciences

    Dr Herve Chneiweiss

  105. Trop court traité de l’âme :Court Traité de l’âme(Philippe Lazar)

    Article • médecine/sciences, December 2008, EDP Sciences

    Dr Herve Chneiweiss

  106. Voyage autour du monde dans le regard de l’autre :L’homme pluriel

    Article • médecine/sciences, December 2008, EDP Sciences

    Dr Herve Chneiweiss

  107. Quand l’art rencontre la science

    Article • médecine/sciences, December 2007, EDP Sciences

    Dr Herve Chneiweiss

  108. The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway

    Article • Oncogene, August 2007, Springer Science + Business Media

    Dr Herve Chneiweiss

  109. Une dimension de plus en plus individualisée du rapport bénéfice/risque

    Article • médecine/sciences, August 2007, EDP Sciences

    Dr Herve Chneiweiss

  110. Contrats et vivant  : le droit de la circulation des ressources biologiques Florence Bellivier, Christine Noiville

    Article • médecine/sciences, June 2007, EDP Sciences

    Dr Herve Chneiweiss

  111. PED/PEA-15 Regulates Glucose-Induced Insulin Secretion by Restraining Potassium Channel Expression in Pancreatic  -Cells

    Article • Diabetes, February 2007, American Diabetes Association

    Dr Herve Chneiweiss

  112. Phosphoprotein Enriched in Astrocytes-15 kDa Expression Inhibits Astrocyte Migration by a Protein Kinase Cδ-dependent Mechanism

    Article • Molecular Biology of the Cell, December 2006, American Society for Cell Biology (ASCB)

    Dr Herve Chneiweiss

  113. Transforming growth factor α promotes sequential conversion of mature astrocytes into neural progenitors and stem cells

    Article • Oncogene, October 2006, Springer Science + Business Media

    Dr Herve Chneiweiss

  114. Do Secretin and Vasoactive Intestinal Peptide Have Independent Receptors on Striatal Neurons and Glial Cells in Primary Cultures?

    Article • Journal of Neurochemistry, October 2006, Wiley

    Dr Herve Chneiweiss

  115. Akt Down-Regulates ERK1/2 Nuclear Localization and Angiotensin II-induced Cell Proliferation through PEA-15

    Article • Molecular Biology of the Cell, September 2006, American Society for Cell Biology (ASCB)

    Dr Herve Chneiweiss

  116. Transforming growth factor alpha acts as a gliatrophin for mouse and human astrocytes

    Article • Oncogene, March 2006, Springer Science + Business Media

    Dr Herve Chneiweiss

  117. Chroniques bioéthiques (13) : Enfin, les cellules souches embryonnaires humaines françaises ont leur décret d’application !

    Article • médecine/sciences, March 2006, EDP Sciences

    Dr Herve Chneiweiss

  118. Cloningate? La publication scientifique et le clonage thérapeutique face à la mystification Hwang

    Article • médecine/sciences, February 2006, EDP Sciences

    Dr Herve Chneiweiss

  119. Et l’épilepsie devint une maladie de l’astrocyte

    Article • médecine/sciences, December 2005, EDP Sciences

    Dr Herve Chneiweiss

  120. Mise en évidence de cellules souches tumorales au sein des tumeurs glio-neuronales malignes (TGNM)

    Article • Neurochirurgie, February 2005, Elsevier

    Dr Herve Chneiweiss

  121. Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila

    Article • Human Molecular Genetics, January 2005, Oxford University Press (OUP)

    Dr Herve Chneiweiss

  122. Brève esquisse neurophysiologique de l'excitation : des neurones, des astrocytes et des images

    Article • Revue française de psychanalyse, January 2005, CAIRN

    Dr Herve Chneiweiss

  123. New Variants of Malignant Glioneuronal Tumors: A Clinicopathological Study of 40 Cases

    Article • Neurosurgery, December 2004, Oxford University Press (OUP)

    Dr Herve Chneiweiss

  124. p38/SAPK2 controls gap junction closure in astrocytes

    Article • Glia, January 2004, Wiley

    Dr Herve Chneiweiss

  125. The expression of PEA-15 (phosphoprotein enriched in astrocytes of 15 kDa) defines subpopulations of astrocytes and neurons throughout the adult mouse brain

    Article • Neuroscience, January 2004, Elsevier

    Dr Herve Chneiweiss

  126. PEA-15 Modulates TNFα Intracellular Signaling in Astrocytes

    Article • Annals of the New York Academy of Sciences, December 2003, Wiley

    Dr Herve Chneiweiss

  127. The multifunctional protein PEA-15 is involved in the control of apoptosis and cell cycle in astrocytes

    Article • Biochemical Pharmacology, October 2003, Elsevier

    Dr Herve Chneiweiss

  128. Sur les rivages de la misère

    Article • médecine/sciences, August 2003, EDP Sciences

    Dr Herve Chneiweiss

  129. Sur les sentiers escarpés des montagnes de bioéthique

    Article • médecine/sciences, May 2003, EDP Sciences

    Dr Herve Chneiweiss

  130. Dans les grandes plaines de la génomique

    Article • médecine/sciences, April 2003, EDP Sciences

    Dr Herve Chneiweiss

  131. Sur les sentiers escarpés des montagnes de bioéthique

    Article • médecine/sciences, March 2003, EDP Sciences

    Dr Herve Chneiweiss

  132. Sur les sentiers escarpés des montagnes de bioéthique

    Article • médecine/sciences, February 2003, EDP Sciences

    Dr Herve Chneiweiss

  133. Cellular Expression, Developmental Regulation, and Phylogenic Conservation of PEA-15, the Astrocytic Major Phosphoprotein and Protein Kinase C Substrate

    Article • Journal of Neurochemistry, November 2002, Wiley

    Dr Herve Chneiweiss

  134. Endothelin Induces a Calcium-Dependent Phosphorylation of PEA-15 in Intact Astrocytes: Identification of Ser104 and Ser116 Phosphorylated, Respectively, by Protein Kinase C and Calcium/Calmodulin Kinase II In Vitro

    Article • Journal of Neurochemistry, November 2002, Wiley

    Dr Herve Chneiweiss

  135. Les astrocytes contrôlent la neurogenèse dans le système nerveux central adulte

    Article • médecine/sciences, November 2002, EDP Sciences

    Dr Herve Chneiweiss

  136. PEA-15 Mediates Cytoplasmic Sequestration of ERK MAP Kinase

    Article • Developmental Cell, August 2001, Elsevier

    Dr Herve Chneiweiss

  137. Keeping TNF-induced apoptosis under control in astrocytes: PEA-15 as a ‘double key’ on caspase-dependent and MAP-kinase-dependent pathways

    Article • January 2001, Elsevier

    Dr Herve Chneiweiss

  138. Death Effector Domain Protein PEA-15 Potentiates Ras Activation of Extracellular Signal Receptor-activated Kinase by an Adhesion-independent Mechanism

    Article • Molecular Biology of the Cell, September 2000, American Society for Cell Biology (ASCB)

    Dr Herve Chneiweiss

  139. Regulation of Expression of Phospholipase D1 and D2 by PEA-15, a Novel Protein That Interacts with Them

    Article • Journal of Biological Chemistry, August 2000, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Herve Chneiweiss

  140. Knock-Out of the Neural Death Effector Domain Protein PEA-15 Demonstrates That Its Expression Protects Astrocytes from TNFα-Induced Apoptosis

    Article • Journal of Neuroscience, October 1999, Society for Neuroscience

    Dr Herve Chneiweiss

  141. Polyneuropathy in autosomal dominant cerebellar ataxias: Phenotype-genotype correlation

    Article • Muscle & Nerve, June 1999, Wiley

    Dr Herve Chneiweiss

  142. Molecular and Clinical Correlations in Spinocerebellar Ataxia 2: A Study of 32 Families

    Article • Human Molecular Genetics, May 1997, Oxford University Press (OUP)

    Dr Herve Chneiweiss

  143. Percevoir n'est pas voir.

    Article • médecine/sciences, January 1997, INIST-CNRS

    Dr Herve Chneiweiss

  144. The Major Astrocytic Phosphoprotein PEA-15 Is Encoded by Two mRNAs Conserved on Their Full Length in Mouse and Human

    Article • Journal of Biological Chemistry, June 1996, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Herve Chneiweiss

  145. Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies): Genetic analysis of three unrelated SCA2 families

    Article • Human Genetics, May 1996, Springer Science + Business Media

    Dr Herve Chneiweiss

  146. Spinocerebellar ataxia 3 and machado-joseph disease: Clinical, molecular, and neuropathological features

    Article • Annals of Neurology, April 1996, Wiley

    Dr Herve Chneiweiss

  147. Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies): genetic analysis of three unrelated SCA2 families

    Article • Human Genetics, March 1996, Springer Science + Business Media

    Dr Herve Chneiweiss

  148. Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse

    Article • Journal of Neuroscience, November 1995, Society for Neuroscience

    Dr Herve Chneiweiss

  149. SCA2 is not a major locus for ADCA type I in French families

    Article • American Journal of Medical Genetics, October 1995, Wiley

    Dr Herve Chneiweiss

  150. Gender equality in Machado–Joseph disease

    Article • Nature Genetics, October 1995, Springer Science + Business Media

    Dr Herve Chneiweiss

  151. Analysis of the SCAI CAG repeat in a large number of families with dominant ataxia: Clinical and molecular correlations

    Article • Annals of Neurology, February 1995, Wiley

    Dr Herve Chneiweiss

  152. Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies)

    Article • Brain, January 1995, Oxford University Press (OUP)

    Dr Herve Chneiweiss

  153. Is DRPLA also linked to 14q?

    Article • Nature Genetics, January 1994, Springer Science + Business Media

    Dr Herve Chneiweiss

  154. Phenotypic variability in autosomal dominant cerebellar ataxia type I is unrelated to genetic heterogeneity

    Article • Brain, December 1993, Oxford University Press (OUP)

    Dr Herve Chneiweiss

  155. Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23–24.1

    Article • Nature Genetics, July 1993, Springer Science + Business Media

    Dr Herve Chneiweiss

  156. Expression of transfected stathmin cDNA reveals novel phosphorylated forms associated with developmental and functional cell regulation

    Article • Biochemical Journal, October 1992, Portland Press Ltd.

    Dr Herve Chneiweiss

  157. Stathmin Phosphorylation Is Regulated in Striatal Neurons by Vasoactive Intestinal Peptide and Monoamines via Multiple Intracellular Pathways

    Article • Journal of Neurochemistry, January 1992, Wiley

    Dr Herve Chneiweiss

  158. Cyclic AMP Accumulation Induces a Rapid Desensitization of the Cyclic AMP-Dependent Protein Kinase in Mouse Striatal Neurons

    Article • Journal of Neurochemistry, November 1991, Wiley

    Dr Herve Chneiweiss

  159. Stathmin phosphorylation patterns discriminate between distinct transduction pathways of human T lymphocyte activation through CD2 triggering

    Article • FEBS Letters, August 1991, Wiley

    Dr Herve Chneiweiss

  160. Dopamine-induced homologous and heterologous desensitizations of adenylate cyclase-coupled receptors on striatal neurons

    Article • European Journal of Pharmacology Molecular Pharmacology, October 1990, Elsevier

    Dr Herve Chneiweiss

  161. CD2 triggers protein phosphorylations related to proliferation in PKC-down regulated human T lymphocytes

    Article • Cell Biology International Reports, September 1990, Wiley

    Dr Herve Chneiweiss

  162. Stathmin Is a Major Phosphoprotein and Cyclic AMP-Dependent Protein Kinase Substrate in Mouse Brain Neurons but Not in Astrocytes in Culture: Regulation During Ontogenesis

    Article • Journal of Neurochemistry, September 1989, Wiley

    Dr Herve Chneiweiss

  163. Cyclic AMP reduces adhesion of isolated neuronal growth cones from developing rat forebrain to an astrocytic cell line from embryonic mouse striatum

    Article • Neuroscience, January 1989, Elsevier

    Dr Herve Chneiweiss

  164. Cyclic-amp dependent protein kinase in mouse striatal neurones and astrocytes in primary culture: development, subcellular distribution and stimulation of endogenous phosphorylation

    Article • Neurochemistry International, January 1989, Elsevier

    Dr Herve Chneiweiss

  165. Somatostatin receptors on cortical neurones and adenohypophysis: comparison between specific binding and adenylate cyclase inhibition

    Article • European Journal of Pharmacology, June 1987, Elsevier

    Dr Herve Chneiweiss

  166. Two simian virus 40 (SV40)-transformed cell lines from the mouse striatum and mesencephalon presenting astrocytic characters. I. Immunological and pharmacological properties

    Article • Developmental Brain Research, April 1986, Elsevier

    Dr Herve Chneiweiss

  167. Modulation by Monoamines of Somatostatin-Sensitive Adenylate Cyclase on Neuronal and Glial Cells from the Mouse Brain in Primary Cultures

    Article • Journal of Neurochemistry, June 1985, Wiley

    Dr Herve Chneiweiss

  168. Vasoactive Intestinal Polypeptide Receptors Linked to an Adenylate Cyclase, and Their Relationship with Biogenic Amine- and Somatostatin-Sensitive Adenylate Cyclases on Central Neuronal and Glial Cells in Primary Cultures

    Article • Journal of Neurochemistry, March 1985, Wiley

    Dr Herve Chneiweiss

  169. VIP and secretin receptors linked to an adenylate cyclase on central neuronal and glial cells in primary cultures

    Article • Regulatory Peptides, January 1985, Elsevier

    Dr Herve Chneiweiss

  170. Biogenic amine-sensitive adenylate cyclases in primary culture of neuronal or glial cells from mesencephalon

    Article • Brain Research, June 1984, Elsevier

    Dr Herve Chneiweiss